Submit Manuscript

Most Accessed Articles

Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?

Author(s):Simone Cappelletti, Daria Piacentino, Gabriele Sani and Mariarosaria Aromatario

[Volume:13 Issue:1]
Pages: 71-88 (18)
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders

Author(s):Jennifer C. Felger*

[Volume:16 Issue:5]
Pages: 533-558 (26)
Neural Network Alterations Across Eating Disorders: A Narrative Review of fMRI Studies

Author(s):Trevor Steward, Jose M. Menchon, Susana Jiménez-Murcia, Carles Soriano-Mas* and Fernando Fernandez-Aranda*

[Volume:16 Issue:8]
Pages: 1150-1163 (14)
Alzheimer's disease: Targeting the Cholinergic System

Author(s):Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva and Fabiola M. Ribeiro

[Volume:14 Issue:1]
Pages: 101-115 (15)
Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects

Author(s):Nitin Chitranshi*, Yogita Dheer, Mojdeh Abbasi, Yuyi You, Stuart L Graham and Vivek Gupta

[Volume:16 Issue:7]
Pages: 1018-1035 (18)
E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure

Author(s):Elise E. DeVito* and Suchitra Krishnan-Sarin

[Volume:16 Issue:4]
Pages: 438-459 (22)
Levodopa in Parkinson’s Disease: Current Status and Future Developments

Author(s):Nicola Tambasco*, Michele Romoli and Paolo Calabresi

[Volume:16 Issue:8]
Pages: 1239-1252 (14)
Strategies to Reduce Oxidative Stress in Glaucoma Patients

Author(s):Maria D. Pinazo-Duran*, Kian Shoaie-Nia, Vicente Zanon-Moreno, Silva M. Sanz-Gonzalez, Javier Benitez del Castillo and Jose J. Garcia-Medina

[Volume:16 Issue:7]
Pages: 903-918 (16)
Experimental Drugs for Neuropathic Pain

Author(s):Kinga Salat*, Beata Gryzlo and Katarzyna Kulig

[Volume:16 Issue:8]
Pages: 1193-1209 (17)